Covered recipient · General Payments record
NICHOLAS BRADLEY GRISSOM
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2025
$1,457.77
- Reported across 49 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $792.47 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nova Eye, Inc. | $365.69 | 1 |
| Alcon Vision LLC | $172.37 | 7 |
| Amgen Inc. | $61.20 | 3 |
| Dompe US, Inc. | $46.58 | 2 |
| Harrow Eye, LLC | $39.01 | 1 |
| ABBVIE INC. | $33.10 | 1 |
| Tarsus Pharmaceuticals, Inc. | $31.48 | 1 |
| Astellas Pharma US Inc | $22.58 | 1 |
| GLAUKOS CORPORATION | $20.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.10 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201967919 | CMS |
| Alcon Vision LLC | $28.00 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488790 | CMS |
| Alcon Vision LLC | $25.31 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488792 | CMS |
| Alcon Vision LLC | $22.27 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488828 | CMS |
| Alcon Vision LLC | $21.21 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488844 | CMS |
| Alcon Vision LLC | $30.96 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488882 | CMS |
| Alcon Vision LLC | $24.88 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488900 | CMS |
| Alcon Vision LLC | $19.74 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207488926 | CMS |
| Amgen Inc. | $22.01 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228514023 | CMS |
| Amgen Inc. | $21.02 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228514019 | CMS |
| Amgen Inc. | $18.17 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228514021 | CMS |
| Astellas Pharma US Inc | $22.58 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238651307 | CMS |
| Dompe US, Inc. | $32.58 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248879031 | CMS |
| Dompe US, Inc. | $14.00 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248879033 | CMS |
| Glaukos Corporation | $20.46 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246421426 | CMS |
| Harrow Eye, LLC | $39.01 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236222189 | CMS |
| Nova Eye, Inc. | $365.69 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251699918 | CMS |
| Tarsus Pharmaceuticals, Inc. | $31.48 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233858947 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.